Rapid reduction of substantially increased myoglobin and creatine kinase levels using a hemoadsorption device (CytoSorb
CytoSorb®
acute kidney injury
myoglobin
renal replacement therapy
rhabdomyolysis
Journal
Clinical case reports
ISSN: 2050-0904
Titre abrégé: Clin Case Rep
Pays: England
ID NLM: 101620385
Informations de publication
Date de publication:
Jan 2022
Jan 2022
Historique:
received:
19
08
2021
revised:
20
12
2021
accepted:
25
12
2021
entrez:
26
1
2022
pubmed:
27
1
2022
medline:
27
1
2022
Statut:
epublish
Résumé
Rhabdomyolysis (RM) is a potentially life-threatening entity that can lead to acute kidney injury (AKI). Continuous renal replacement therapy (CRRT) alone is known as effective therapy, but the additional use of a hemoadsorber (like CytoSorb
Identifiants
pubmed: 35079387
doi: 10.1002/ccr3.5272
pii: CCR35272
pmc: PMC8777160
doi:
Types de publication
Case Reports
Langues
eng
Pagination
e05272Informations de copyright
© 2022 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd.
Déclaration de conflit d'intérêts
None declared.
Références
Urology. 2002 Nov;60(5):911
pubmed: 12429334
Crit Care. 2016 Jun 15;20(1):135
pubmed: 27301374
Biomedicines. 2020 Nov 26;8(12):
pubmed: 33255912
Ochsner J. 2015 Spring;15(1):58-69
pubmed: 25829882
Blood Purif. 2017;43(1-3):57-67
pubmed: 27915348
Intensive Care Med. 2017 Jun;43(6):855-866
pubmed: 28466146
Clin Case Rep. 2022 Jan 20;10(1):e05272
pubmed: 35079387
Cochrane Database Syst Rev. 2014 Jun 15;(6):CD008566
pubmed: 24929959
Blood Purif. 2021;50(2):268-269
pubmed: 32535606
J Thorac Dis. 2018 Mar;10(Suppl 5):S653-S660
pubmed: 29732183
Blood Purif. 2019;48(3):196-202
pubmed: 31039564
J Clin Anesth. 2007 Feb;19(1):64-6
pubmed: 17321931
J Clin Neurosci. 2019 Dec;70:178-182
pubmed: 31447366
Blood Purif. 2020;49(6):743-747
pubmed: 32114569